Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy.
about
Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory AntibodiesBroadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune SystemAdvancements in Developing Strategies for Sterilizing and Functional HIV Cures.A novel mechanism linking memory stem cells with innate immunity in protection against HIV-1 infectionExtracellular Vesicles Carry HIV Env and Facilitate Hiv Infection of Human Lymphoid Tissue.Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis.Role of Natural Killer Cells in HIV-Associated Malignancies.Landscape review of current HIV 'kick and kill' cure research - some kicking, not enough killing.Persistent accumulation of gut macrophages with impaired phagocytic function correlates with SIV disease progression in macaques.Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.ImmunoPET Imaging of Murine CD4+ T Cells Using Anti-CD4 Cys-Diabody: Effects of Protein Dose on T Cell Function and Imaging.Complex immune correlates of protection in HIV-1 vaccine efficacy trials.Fight fire with fire: Gene therapy strategies to cure HIV.Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure.Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with α4β7.HIV-1 selectively targets gut-homing CCR6+CD4+ T cells via mTOR-dependent mechanisms.Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing.An entry-competent intermediate state of the HIV-1 envelope glycoproteins.Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin.Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies.Tackling HIV and AIDS: contributions by non-human primate models.HIV: Achieving sustained remission.Shock and kill with caution.Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity.The HIV-1 transmission bottleneck.Highlights from the Third Biennial Strategies for an HIV Cure Meeting: 14-16 November 2016, Bethesda, MD, USA.Highlights from the HIV Research for Prevention Conference (R4P),: 17-21 October 2016, Chicago, IL, USA.Converging roads: the latest science from the 2017 IAS HIV Cure and Cancer Forum.Nonhuman Primate Models and Understanding the Pathogenesis of HIV Infection and AIDS.Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant.Reasons for optimism in the search for new vaccines for tuberculosis.Integrin α4β7 Blockade Preferentially Impacts CCR6+ Lymphocyte Subsets in Blood and Mucosal Tissues of Naive Rhesus Macaques.Treatment-Naïve HIV-Infected Patients Have Fewer Gut-Homing β7 Memory CD4 T Cells than Healthy Controls.Early treatment of SIV+ macaques with an α4β7 mAb alters virus distribution and preserves CD4+ T cells in later stages of infection.Towards a cure for human immunodeficiency virus.Mathematical Models of HIV Latency.Harnessing Novel Imaging Approaches to Guide HIV Prevention and Cure Discoveries-A National Institutes of Health and Global HIV Vaccine Enterprise 2017 Meeting Report.ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment.Immune Interventions to Eliminate the HIV Reservoir.
P2860
Q28066335-C9BF5505-B2AC-409C-8482-5C6B4C1B8905Q33592852-B8010FB8-409C-4056-AC4C-AC985B49080DQ33654409-35C7B912-EF76-49A2-B0A5-FE19593290D0Q33683355-9DBCDA28-DB2C-4F6D-80BE-C5C3AB0AE188Q33687702-F990C56A-3751-4C8F-B5D2-209DEA31C533Q33804531-DA019108-AB9A-4289-A7A1-3539D50436EAQ37691599-741FD117-AC28-4B8D-9619-4AD562FC1119Q37712593-3EFE3F28-AD9D-43A9-B525-EBE4D7480643Q38636019-E278063F-2A43-45A0-85CC-152798E6A75AQ38698973-C467AE4F-B1E8-49EF-9CB1-0BA617CBC4EAQ38777005-7585C221-D051-416D-A408-A81E35A2B6EDQ38783061-529D550B-997B-424D-AA26-98BF7EEEF477Q39108779-5910F393-1C14-4586-999C-137B3C3A5FC1Q39425614-A8B319BA-EDB3-40D5-A2CB-F07A0A35B232Q40053061-DE819B66-B554-4CA1-901F-CF1674E036F9Q40080908-C560D40C-CBA8-4EB2-A1C5-6E7737F780C7Q40097445-E72168D8-0B45-4F08-9507-6BD2F764F27AQ40099506-70BEF3E4-C6D1-437F-A9B1-DE5E6608CF27Q40104677-25E42391-2148-4033-B9DB-15BFD8BA5260Q40174150-BC4CE47C-BFCC-4F08-A8C4-C3CED5665D6FQ40174154-368F8B97-0093-4CF6-9000-6CAB1A2CE334Q40191155-82598E50-4C7A-456D-9133-8DB772F098D9Q40447212-13108380-CCA5-4C12-8948-A15C38E448FEQ40507710-9413D8EB-1A5D-4E33-8877-BC071D94CFAAQ41924059-63372826-E2CD-4715-B070-1D25C95430EAQ42314454-4FA50F78-28D1-4CFA-B0D4-72A144B63E49Q42318283-F261E239-656C-4BC2-B250-A69F33EABF25Q42365531-DA8460AE-380C-43AD-812D-F964B374DABEQ46063211-66BB0E0F-23B7-4C45-AD48-E9DAE792E059Q46243818-90F872C3-3420-4C7B-B259-6395DCF64F75Q47105347-7A9BB230-5B55-4A42-A208-95093C399BA7Q47327109-779A20DE-AB1B-41BA-9447-5F1DBEC08793Q47381745-77157721-44A9-4504-ABDA-661405417F0DQ47444677-8B04AA85-E705-47EC-BC13-8FB9A3F1CEF5Q47551858-680CC790-91F9-4FB5-8702-A0967AEE9EDFQ47556728-96500D66-6DCC-4C58-81BF-2CB2780E771AQ47574091-EF4FCFE6-BE84-4A46-84FE-18E0769838AFQ47577794-65AFA54D-BD6E-4BDF-9247-57EC862DE74CQ47585968-DF3240BE-AF97-46B1-BB02-6F4698D5CA8FQ47600062-797CC9FD-F3CD-4DD8-BC37-CF19F70FBC8D
P2860
Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Sustained virologic control in ...... ral and α4β7 antibody therapy.
@en
type
label
Sustained virologic control in ...... ral and α4β7 antibody therapy.
@en
prefLabel
Sustained virologic control in ...... ral and α4β7 antibody therapy.
@en
P2093
P2860
P50
P356
P1433
P1476
Sustained virologic control in ...... ral and α4β7 antibody therapy.
@en
P2093
Aftab A Ansari
Ann E Mayne
Anthony S Fauci
Caroline E Woody
Chiara Zurla
Christian Roos
Claudia Cicala
Dawn Little
Donald Van Ryk
Francois Villinger
P2860
P304
P356
10.1126/SCIENCE.AAG1276
P407
P577
2016-10-01T00:00:00Z